Delivery Order SPM20005D2206-EZ67
- Not listed
- This federal contract award, valued at $123,367.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order under the TRICARE SOUTH program, which provides healthcare services to military personnel, veterans, and their families. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award is for a delivery order under the TRICARE South contract, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $102,889.80, is a firm fixed-price agreement for the delivery of medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $115,686.07, is a Firm Fixed Price Delivery Order to provide a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, is...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to support TRICARE, the military healthcare program. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $130,224.02 firm fixed-price delivery order contract has an ultimate completion date of July 27, 2015. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,443.27, is a Firm Fixed Price Delivery Order to provide a range of pharmaceutical products and medical supplies to support TRICARE South, the managed healthcare program for military members, retirees, and their families. The contract has no set-aside designation, indicating open...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $78,364.50, is a Firm Fixed Price Delivery Order for the provision of TRICARE medical supplies to support the DLA's healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is a delivery order valued at $100,167.09, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRICARE South medical supplies, with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,950.46, is a Firm Fixed Price Delivery Order for medical supplies to support the TRICARE South healthcare program. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for a delivery order under the TRICARE South program, valued at $81,217.67. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of a comprehensive range of pharmaceutical products, medical supplies, and equipment to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government's Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,139.70 and an ultimate completion date of January 12, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPM20005D2206Indefinite Delivery Contract
- SPM20005D2206-EZ67Delivery Order
This federal contract award is for the delivery of a range of pharmaceutical products and medical supplies to support the TRICARE South healthcare program. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $89,883.82 and a firm fixed-price delivery order type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.9k | 4/3/15 |